Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: Application to single-dose pharmacokinetic studies

37Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Zolpidem, an imidazopyradine hypnotic agent, can be quantitated by high- performance liquid chromatography (HPLC) with fluorescence detection. After the addition of a structurally related internal standard (propyl-zolpidem), plasma samples were double-extracted at neutral pH with toluene-isoamyl alcohol or benzene-isoamyl alcohol. The organic extracts were evaporated to dryness, reconstituted with mobile phase, and analyzed by HPLC using a C-18 reversed-phase column, a mobile phase of acetonitrile-50mM potassium dihydrogen phosphate (50:50), and fluorescence detection with excitation and emission wavelengths of 254 and 390 nm, respectively. The lower limit of reliable quantitation was in the range of 1-2.5 ng/mL. The method is applicable to single-dose pharmacokinetic studies of zolpidem in humans.

Cite

CITATION STYLE

APA

Durol, A. L. B., & Greenblatt, D. J. (1997). Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: Application to single-dose pharmacokinetic studies. Journal of Analytical Toxicology, 21(5), 388–392. https://doi.org/10.1093/jat/21.5.388

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free